NCT03865511 MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03863184 Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03853187 Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT03851614 Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03848156 Characterisation of Nasal Polyps in Patients With and Without Aspirin-exacerbated Respiratory Disease Status COMPLETED Phase N/A
NCT03848052 Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Status RECRUITING Phase N/A
NCT03847649 A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies Status RECRUITING Phase PHASE2
NCT03847428 Assess Efficacy and Safety of Durvalumab Alone or Combined With Bevacizumab in High Risk of Recurrence HCC Patients After Curative Treatment Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03843060 A Phase 1 Study to Assess the Pharmacokinetics of AZD9977 Administered Alone and in Combination With Itraconazole in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03838744 Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. Status COMPLETED Phase PHASE2
NCT03837899 Durvalumab and Tremelimumab for Pediatric Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03836677 A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD Status COMPLETED Phase PHASE3
NCT03836599 A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects Status COMPLETED Phase PHASE1
NCT03836469 Retrospective Epidemiological Study of Locally Advanced Non Small Cell Lung Cancer Patients in Brazil Status COMPLETED Phase N/A
NCT03836261 Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03833154 Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03833141 Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab. Status COMPLETED Phase N/A
NCT03830866 Study of Durvalumab With Chemoradiotherapy for Women With Locally Advanced Cervical Cancer (CALLA) Status COMPLETED Phase PHASE3